Clinical Trials Development Resource for Hematologic Disorders (U24)

Archived

National Institutes of Health

Description

This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI) invites applications to provide a Resource of expert consultants to assist investigators in the development of multi-site clinical trials for hematologic disorders supported by the Clinical Trials Planning Studies for Rare Thrombotic and Hemostatic Disorders (U34) (RFA-HL-12-023) and the NHLBI Clinical Trial Pilot Studies (R34) (PAR-10-005) awards. Academic institutions, particularly those with Clinical Trial Units, School of Public Health and Clinical and/or Translational Science Awards (CTSA) programs, are encouraged to apply.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedMay 2, 2011
  • ClosesOct 13, 2011
  • Award ceiling$300,000
  • CFDA93.839
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro